| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
FOSTER CITY, Calif. – Applied Biosystems in mid-March introduced a new plan, the Advanced Gene Expression Service Provider Program (AGESPP), to sell varying combinations of instrumentation, supplies, services, and marketing support in custom-made bundles at discounted prices. The company initially plans to target core facilities and for-profit service providers, says Dr. Angelique Habis, associate manager, Expression Array System.
 
The program's goal, says Habis, is "nationally penetrating the academic or basic scientific research market" and increasing availability of Applied Bio's technology to small- and medium-sized biotechnology companies as well as researchers affiliated with hospitals. Habis acknowledged that the company entered the gene expression market late, but said the company hopes AGESPP will open doors to customers interested in completing gene expression systems or offering broader arrays of gene expression services to clients who are not likely to purchase large capital equipment.
 
Carl Hull, vice president and general manager of real-time PCR systems and microarrays at Applied Biosystems, said the company is publicizing the program through "a banner for the AGESPP [that] rotates on the homepage of the AB web site. Additionally, information about the program is listed on the Expression Array System marketing page." He said the company has a policy of not releasing sales forecast information.
 
Because every service provider has "specific requirements that separate them from other types of customers," Habis says Applied Bio will work with clients to help them determine custom combinations of items—from capital equipment to consumables—that best complete customers' existing gene expression offerings. "We don't require a fee to get involved in the core facility or service provider program," says Habis, and bundling will decrease costs while increasing ROI and cost-effectiveness for service providers.
 
Applied Bi also provides technical support with installation and data analysis, and customers will have access to database information on gene expression. The Applied Biosystems Expression Array System incorporates data from both the public and Celera Genomics efforts to sequence the human genome. The Celera Genomics Group is Applied Biosystems' sister company in the Applera Corp.

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue